REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.625
Bid: 7.50
Ask: 7.75
Change: 0.00 (0.00%)
Spread: 0.25 (3.333%)
Open: 8.125
High: 0.00
Low: 0.00
Prev. Close: 7.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Information Update

7 Feb 2011 12:18

RNS Number : 7974A
Phytopharm PLC
07 February 2011
 

Phytopharm plc

 

Annual Information Update

 

Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 31 January 2011, the following information has been published or made available to the public between 14 December 2009 and 7 February 2011 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.

1. Announcements made via the Regulatory Information Service ("RIS")

All the announcements listed below were published through a regulatory information service on the dates indicated. Copies can be obtained from the London Stock Exchange website, http://www.londonstockexchange.com or from the Company's website www.phytopharm.com

Date of publication

Title

1 February 2011

Total voting rights

1 February 2011

Annual Report 2010 and notice of 2011 AGM

19 January 2011

Director/PDMR shareholding

19 January 2011

Director/PDMR shareholding

14 January 2011

Holdings in Company

10 January 2011

Holdings in Company

7 January 2011

Block Listing Application

4 January 2011

Total voting rights

21 December 2010

Director/PDMR shareholding

21 December 2010

Director/PDMR shareholding

14 December 2010

Block Listing application

30 November 2010

Final results

17 November 2010

Research update

3 November 2010

Block listing interim review

1 November 2010

Preliminary results - change of date

1 November 2010

Notice of preliminary results

29 September 2010

Presentation at scientific conference

18 August 2010

Interim management statement

22 July 2010

Director/PDMR shareholding

22 July 2010

Director/PDMR shareholding

5 July 2010

Change of registered office

21 June 2010

Appointment of Chief Executive Officer

14 June 2010

Regulatory approval to begin Cogane™ Phase II trial

24 May 2010

Half yearly report

19 May 2010

Notice of results

4 May 2010

Block listing interim review

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

31 March 2010

Results of Annual General Meeting

2 March 2010

Notice of Annual General Meeting

11 February 2010

Interim Management Statement

15 January 2010

Appointment of R & D Director

5 January 2010

Holding in company

4 January 2010

Total voting rights

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

29 December 2009

GM results

22 December 2009

Open Offer results

15 December 2009

Correction to Form of Proxy

15 December 2009

Annual Information update

14 December 2009

Presents data at XVIII WFN Congress

2. Documents published or sent to Shareholders, filed with the UK Listing Authority or submitted to the FSA including those filed with the National Storage Mechanism:

Date of publication

Title

1 February 2011

Notice of 2011 Annual General Meeting

1 February 2011

Annual Report 2010

2 June 2010

Interim Report 2010

31 March 2010

AGM resolutions

2 March2010

Notice of Annual General Meeting

30 December 2009

General Meeting resolutions

The 2010 Interim and 2010 Annual reports are available on the Company's website www.phytopharm.com

3. Documents filed at Companies House

The following documents were files at Companies House. Copies of these documents can be obtained from the Companies House website at www.companieshouse.gov.uk, or Companies House, Crown Way, Cardiff CF14 3UZ

Date of Publication

Title

25 January 2011

Form SH01 Return of allotment of shares on 14 January 2011

5 January 2011

Form SH01 Return of allotment of shares on 16 December 2010

16 December 2010

Form AR01 Annual return

6 July 2010

Form AP01 Appointment of director

6 July 2010

Form AD01 change of registered office address

31 March 2010

Articles of Association approved by shareholders on 30 march 2010

31 March 2010

Annual General Meeting resolutions

25 January 2010

Form AP01 Appointment of director

4 January 2010

Form SH01 Return of allotment of shares on 29 December 2009

Copies of all documents referred to above are also available for inspection at the Company's registered office (Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambs PE29 6UA, United Kingdom) during normal business hours or by written request from the Company Secretary.

This annual information is required by, and is being made pursuant to, Article 10 of the Prospectus Directive as implemented by the UK Prospectus Rule 5.2 and not for any other purpose and neither the Company, nor any other person, takes any responsibility for, or makes any representation, express of implied, as to the accuracy or completeness of, the information which it contains. The information is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Neither this annual information update, not referred to in it, constitutes, by virtue of this communication, an offer of securities addressed to any person and it should not be relied on by any person.

For further information, please contact:

Zoe McGowan, Company Secretary

Phytopharm plc Tel No: +44 (0)1480 437697

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUEAAAXEFAFEFF
Date   Source Headline
7th May 20247:00 amRNSNotice of half year results
15th Apr 20247:00 amRNSLife Molecular Imaging – Neuraceq Supply Agreement
3rd Apr 20247:00 amRNSImeka Collaboration Agreement
13th Mar 20247:00 amRNSTrading Update
29th Jan 202412:00 pmRNSHolding(s) in Company
25th Jan 20244:00 pmRNSResult of AGM
12th Jan 20249:35 amRNSDirectorate Change
27th Dec 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
15th Dec 20237:00 amRNSChange of Auditor
5th Dec 20237:00 amRNSFinancial Results for year ended 30 September 2023
27th Nov 20237:00 amRNSNotice of Results and Investor Presentation
5th Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
29th Sep 20237:00 amRNSTrading Update
18th Jul 20237:00 amRNSContract Win
14th Jun 20237:00 amRNSContract Win
23rd May 20237:00 amRNSHalf year report
16th May 20237:00 amRNSInvestor Meet Company presentation
10th May 20237:00 amRNSTrading Update
3rd Apr 20238:35 amRNSExtension of Huntington's disease consortium
21st Mar 202312:11 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSContract Win
7th Feb 20237:00 amRNSTrading Update
31st Jan 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
27th Jan 20231:00 pmRNSResult of AGM
3rd Jan 20237:00 amRNSTotal Voting Rights
22nd Dec 202212:18 pmRNSDirector Bed & ISA Dealing
13th Dec 20227:00 amRNSPDMR Exercise of Options
9th Dec 20229:05 amRNSContract Win
8th Dec 20223:34 pmRNSContract Update
7th Dec 20227:00 amRNSFinancial Results for the year ended 30 Sept 2022
21st Nov 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 20227:00 amRNSTrading Update
21st Sep 202210:35 amRNSHD-IH Consortium
14th Sep 20227:00 amRNSGrant of Share Options
1st Sep 20227:00 amRNSTrading Update and FY2023 Guidance
4th Aug 20227:00 amRNSContract Win
26th Jul 202211:22 amRNSContract Win - Replacement
21st Jul 20227:00 amRNSContract Win
14th Jun 20227:00 amRNSContract Extension
24th May 20227:00 amRNSHalf-year Report and Trading Update
16th May 20227:00 amRNSInvestor Presentation
10th May 20227:00 amRNSConsortium Agreement in Huntington's Disease
25th Apr 20227:00 amRNSTrading Update
21st Apr 20227:00 amRNSNew Contract Win
8th Mar 20227:00 amRNSContract worth circa £800k
14th Feb 20227:00 amRNSLaunch of IXIQ.Ai Deep learning AI-based platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.